Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig03301 |
kinesin family member 23 |
625 |
20 |
6.41E-79 |
85.50% |
12 |
P:mitotic spindle elongation; P:microtubule-based movement; F:protein binding; P:mitosis; P:cytokinesis; P:embryonic cleavage; C:spindle; F:ATP binding; C:nucleus; C:kinesin complex; F:microtubule motor activity; C:microtubule |
|
|
contig03302 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig03303 |
ubiquitin fusion degradation 1-like |
305 |
20 |
7.96E-28 |
90.35% |
5 |
F:ubiquitin-specific protease activity; F:protein binding; P:ubiquitin-dependent protein catabolic process; P:ubiquitin cycle; P:skeletal system development |
|
|
contig03304 |
---NA--- |
264 |
0 |
|
|
0 |
|
|
|
contig03305 |
deoxyribose-phosphate aldolase-like |
305 |
20 |
8.22E-33 |
79.05% |
4 |
C:cytoplasm; P:deoxyribonucleotide catabolic process; F:deoxyribose-phosphate aldolase activity; F:protein binding |
EC:4.1.2.4 |
|
contig03306 |
---NA--- |
307 |
0 |
|
|
0 |
|
|
|
contig03307 |
---NA--- |
273 |
0 |
|
|
0 |
|
|
|
contig03308 |
x-box binding protein 1 |
261 |
20 |
3.84E-22 |
89.10% |
7 |
C:extracellular space; P:endoplasmic reticulum unfolded protein response; F:sequence-specific DNA binding; F:protein dimerization activity; F:transcription factor activity; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
contig03309 |
---NA--- |
336 |
0 |
|
|
0 |
|
|
|
contig03310 |
fibroblast growth factor receptor substrate 2 |
496 |
20 |
7.60E-38 |
65.70% |
18 |
P:gastrulation with mouth forming second; P:forebrain development; F:transmembrane receptor protein tyrosine kinase adaptor protein activity; P:optic placode formation involved in camera-type eye; P:G-protein coupled receptor protein signaling pathway; F:phosphatase activator activity; P:induction of an organ; C:membrane fraction; P:fibroblast growth factor receptor signaling pathway; F:protein binding; P:neuroblast proliferation; P:anterior/posterior axis specification, embryo; F:transmembrane receptor protein tyrosine kinase docking protein activity; F:regulator of G-protein signaling activity; P:activation of MAPK activity; C:cytoplasm; C:integral to plasma membrane; P:transmembrane receptor protein tyrosine phosphatase signaling pathway |
|
|
contig03311 |
---NA--- |
552 |
0 |
|
|
0 |
|
|
|
contig03312 |
novel protein |
285 |
20 |
2.91E-09 |
53.30% |
0 |
|
|
|
contig03313 |
---NA--- |
980 |
0 |
|
|
0 |
|
|
|
contig03314 |
es1 protein |
602 |
20 |
9.17E-59 |
79.20% |
2 |
F:F; C:C |
|
|
contig03315 |
---NA--- |
317 |
0 |
|
|
0 |
|
|
|
contig03316 |
ras homolog gene member g |
248 |
20 |
4.19E-37 |
91.70% |
11 |
P:Rac protein signal transduction; P:positive regulation of transcription; P:actin cytoskeleton organization; P:positive regulation of cell proliferation; F:GTP binding; P:Rho protein signal transduction; C:intracellular; C:plasma membrane; F:protein binding; C:membrane attack complex; F:GTPase activity |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03317 |
poly (adp-ribose) polymerase member 1 |
245 |
4 |
4.24E-05 |
94.50% |
10 |
F:transferase activity; F:NAD or NADH binding; F:DNA binding; C:nucleus; F:transferase activity, transferring glycosyl groups; P:protein amino acid ADP-ribosylation; F:zinc ion binding; C:intracellular; F:metal ion binding; F:NAD+ ADP-ribosyltransferase activity |
|
|
contig03318 |
---NA--- |
542 |
0 |
|
|
0 |
|
|
|
contig03319 |
---NA--- |
326 |
0 |
|
|
0 |
|
|
|
contig03320 |
---NA--- |
486 |
0 |
|
|
0 |
|
|
|
contig03321 |
family with sequence similarity 122a |
254 |
20 |
6.45E-33 |
90.80% |
2 |
F:F; C:C |
|
|
contig03322 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig03323 |
ceramide glucosyltransferase |
470 |
20 |
5.67E-82 |
95.95% |
8 |
C:integral to membrane; P:epidermis development; C:extracellular space; C:membrane fraction; P:glucosylceramide biosynthetic process; F:ceramide glucosyltransferase activity; P:glycosphingolipid biosynthetic process; C:endoplasmic reticulum membrane |
EC:2.4.1.80 |
|
contig03324 |
---NA--- |
452 |
0 |
|
|
0 |
|
|
|
contig03325 |
block of proliferation 1 |
488 |
20 |
4.00E-27 |
91.45% |
5 |
C:nucleolus; F:ribonucleoprotein binding; P:ribosomal large subunit biogenesis; F:protein binding; P:rRNA processing |
|
|
contig03326 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig03327 |
cenpt protein |
431 |
20 |
1.90E-37 |
65.35% |
1 |
C:intracellular |
|
|
contig03328 |
chromosome 10 open reading frame 119 |
247 |
20 |
2.47E-21 |
85.10% |
0 |
|
|
|
contig03329 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig03330 |
---NA--- |
263 |
0 |
|
|
0 |
|
|
|
contig03331 |
---NA--- |
309 |
0 |
|
|
0 |
|
|
|
contig03332 |
chromosome condensation protein g |
637 |
20 |
3.37E-81 |
80.05% |
5 |
C:cytoplasm; F:binding; C:nucleus; P:cell division; P:mitotic chromosome condensation |
|
|
contig03333 |
---NA--- |
644 |
0 |
|
|
0 |
|
|
|
contig03334 |
---NA--- |
297 |
0 |
|
|
0 |
|
|
|
contig03335 |
v-ral simian leukemia viral oncogene homolog b (ras related gtp binding protein) |
960 |
20 |
2.20E-93 |
95.15% |
8 |
P:actin cytoskeleton organization; P:fibroblast growth factor receptor signaling pathway; F:GTP binding; C:intracellular; C:plasma membrane; P:regulation of developmental pigmentation; F:protein binding; P:Ras protein signal transduction |
|
|
contig03336 |
---NA--- |
296 |
0 |
|
|
0 |
|
|
|
contig03337 |
n-glycanase 1 |
470 |
20 |
1.80E-11 |
72.70% |
4 |
F:peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity; F:metal ion binding; C:cytoplasm; P:zinc ion transport |
EC:3.5.1.52 |
|
contig03338 |
lipase maturation factor 2 |
338 |
20 |
2.53E-42 |
74.30% |
1 |
C:cell part |
|
|
contig03339 |
rio kinase 2 |
606 |
20 |
4.37E-64 |
88.85% |
2 |
F:ATP binding; F:protein serine/threonine kinase activity |
EC:2.7.11.0 |
|
contig03340 |
unnamed protein product [Tetraodon nigroviridis] |
250 |
1 |
3.12E-08 |
82.00% |
0 |
|
|
|
contig03341 |
phosphogluconate dehydrogenase |
710 |
20 |
1.05E-47 |
91.15% |
11 |
C:soluble fraction; P:pentose biosynthetic process; F:phosphogluconate 2-dehydrogenase activity; C:microsome; P:D-gluconate metabolic process; P:pentose-phosphate shunt, oxidative branch; F:carboxylic acid binding; F:protein binding; F:phosphogluconate dehydrogenase (decarboxylating) activity; F:NADP or NADPH binding; F:sugar binding |
EC:1.1.1.43; EC:1.1.1.44 |
|
contig03342 |
---NA--- |
1388 |
0 |
|
|
0 |
|
|
|
contig03343 |
---NA--- |
279 |
0 |
|
|
0 |
|
|
|
contig03344 |
unnamed protein product [Tetraodon nigroviridis] |
256 |
1 |
4.33E-13 |
85.00% |
0 |
|
|
|
contig03345 |
polymerase iii (dna directed) polypeptide b |
498 |
20 |
1.56E-90 |
95.30% |
5 |
P:transcription; F:DNA-directed RNA polymerase activity; C:nucleus; F:DNA binding; F:zinc ion binding |
EC:2.7.7.6 |
|
contig03346 |
---NA--- |
550 |
0 |
|
|
0 |
|
|
|
contig03347 |
inositol polyphosphate-5- 75kda |
785 |
20 |
1.92E-51 |
78.50% |
3 |
C:cytosol; C:integral to membrane; F:inositol-polyphosphate 5-phosphatase activity |
EC:3.1.3.56 |
|
contig03348 |
glucosamine-6-phosphate deaminase 2 |
373 |
20 |
4.41E-48 |
91.15% |
6 |
P:acrosome reaction; F:glucosamine-6-phosphate deaminase activity; P:fructose 6-phosphate metabolic process; P:fructose biosynthetic process; P:N-acetylglucosamine metabolic process; F:hydrolase activity |
EC:3.5.99.6 |
|
contig03349 |
sda1 domain containing 1 |
466 |
20 |
6.02E-07 |
92.65% |
1 |
C:nucleus |
|
|
contig03350 |
necap endocytosis associated 2 |
1379 |
20 |
1.25E-88 |
75.30% |
4 |
C:coated pit; C:clathrin vesicle coat; F:protein binding; P:endocytosis |
|
|
contig03351 |
---NA--- |
120 |
0 |
|
|
0 |
|
|
|
contig03352 |
---NA--- |
310 |
0 |
|
|
0 |
|
|
|
contig03353 |
member ras oncogene family |
372 |
20 |
4.29E-29 |
95.50% |
10 |
P:small GTPase mediated signal transduction; C:zymogen granule; P:regulation of exocytosis; F:protein binding; F:GTPase activity; P:peptidyl-cysteine methylation; P:protein transport; F:GTP binding; C:plasma membrane; P:hemocyte development |
EC:3.6.5.1; EC:3.6.5.2; EC:3.6.5.3; EC:3.6.5.4 |
|
contig03354 |
kunitz-type protease inhibitor 2 |
280 |
4 |
5.31E-16 |
64.25% |
2 |
P:P; C:C |
|
|
contig03355 |
dynactin 2 |
286 |
20 |
1.17E-34 |
75.10% |
13 |
P:mitotic spindle organization; C:dynein complex; C:growth cone; P:cell proliferation; C:kinetochore; C:dynactin complex; F:protein binding; P:mitosis; C:membrane attack complex; C:centrosome; F:motor activity; P:establishment of nucleus localization; C:microtubule |
|
|
contig03356 |
---NA--- |
311 |
0 |
|
|
0 |
|
|
|
contig03357 |
fic domain containing |
353 |
20 |
5.91E-55 |
94.25% |
2 |
C:membrane attack complex; F:protein binding |
|
|
contig03358 |
ubiquitin conjugating enzyme |
885 |
20 |
7.45E-29 |
62.50% |
3 |
; P:cellular protein metabolic process; F:ubiquitin-protein ligase activity |
EC:6.3.2.19 |
|
contig03359 |
---NA--- |
143 |
0 |
|
|
0 |
|
|
|
contig03360 |
tripartite motif-containing 2 |
587 |
20 |
2.68E-84 |
89.25% |
3 |
C:cytoplasm; F:myosin binding; F:zinc ion binding |
|
|
contig03361 |
glutaredoxin 2 |
874 |
20 |
1.35E-83 |
73.45% |
8 |
F:metal ion binding; P:response to pH; F:iron-sulfur cluster binding; P:response to organic substance; F:electron carrier activity; P:response to hydrogen peroxide; F:protein disulfide oxidoreductase activity; C:mitochondrion |
|
|
contig03362 |
---NA--- |
244 |
0 |
|
|
0 |
|
|
|
contig03363 |
a20-binding inhibitor of nf-kappab activation 2 |
1219 |
20 |
1.10E-61 |
59.10% |
2 |
P:I-kappaB kinase/NF-kappaB cascade; F:protein binding |
|
|
contig03364 |
papillary renal cell carcinoma (translocation-associated) |
677 |
20 |
4.42E-61 |
84.70% |
2 |
P:P; C:C |
|
|
contig03365 |
---NA--- |
772 |
0 |
|
|
0 |
|
|
|
contig03366 |
---NA--- |
179 |
0 |
|
|
0 |
|
|
|
contig03367 |
unnamed protein product [Tetraodon nigroviridis] |
290 |
2 |
1.70E-09 |
69.00% |
0 |
|
|
|
contig03368 |
tpr repeat-containing protein ydr161w |
366 |
11 |
2.80E-33 |
63.36% |
0 |
|
|
|
contig03369 |
zinc finger protein 318 |
265 |
5 |
4.15E-08 |
68.20% |
0 |
|
|
|
contig03370 |
zgc:152777 protein |
241 |
6 |
1.56E-07 |
96.33% |
0 |
|
|
|
contig03371 |
---NA--- |
493 |
0 |
|
|
0 |
|
|
|
contig03372 |
---NA--- |
500 |
0 |
|
|
0 |
|
|
|
contig03373 |
chromatin accessibility complex 1 |
403 |
20 |
3.89E-42 |
83.05% |
4 |
F:sequence-specific DNA binding; F:DNA-directed DNA polymerase activity; C:nucleus; F:protein binding |
EC:2.7.7.7 |
|
contig03374 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig03375 |
---NA--- |
507 |
0 |
|
|
0 |
|
|
|
contig03376 |
mitogen-activated protein kinase kinase 4b |
249 |
3 |
4.64E-12 |
91.67% |
0 |
|
|
|
contig03377 |
---NA--- |
932 |
0 |
|
|
0 |
|
|
|
contig03378 |
---NA--- |
284 |
0 |
|
|
0 |
|
|
|
contig03379 |
---NA--- |
514 |
0 |
|
|
0 |
|
|
|
contig03380 |
transmembrane protein 186 |
407 |
5 |
4.26E-13 |
66.40% |
0 |
|
|
|
contig03381 |
---NA--- |
301 |
0 |
|
|
0 |
|
|
|
contig03382 |
prp19 pso4 pre-mrna processing factor 19 homolog |
307 |
20 |
1.50E-26 |
95.95% |
15 |
P:DNA repair; P:inner cell mass cell proliferation; P:lipid biosynthetic process; P:RNA splicing; P:positive regulation of astrocyte differentiation; F:DNA binding; F:ubiquitin-protein ligase activity; P:protein ubiquitination; C:spliceosomal complex; F:protein binding; C:ubiquitin ligase complex; P:positive regulation of neuron differentiation; P:mRNA processing; C:lipid particle; P:negative regulation of neuron differentiation |
EC:6.3.2.19 |
|
contig03383 |
---NA--- |
163 |
0 |
|
|
0 |
|
|
|
contig03384 |
---NA--- |
355 |
0 |
|
|
0 |
|
|
|
contig03385 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig03386 |
---NA--- |
389 |
0 |
|
|
0 |
|
|
|
contig03387 |
comm domain containing 2 |
238 |
20 |
3.04E-27 |
88.40% |
1 |
F:protein binding |
|
|
contig03388 |
sumo-1 activating enzyme subunit 2 |
1211 |
20 |
9.69E-119 |
84.15% |
7 |
F:ligase activity; F:small protein activating enzyme activity; F:enzyme activator activity; F:protein binding; P:ubiquitin cycle; F:ATP binding; C:nucleus |
|
|
contig03389 |
---NA--- |
319 |
0 |
|
|
0 |
|
|
|
contig03390 |
---NA--- |
275 |
0 |
|
|
0 |
|
|
|
contig03391 |
vacuolar protein sorting 11 |
684 |
20 |
4.98E-99 |
80.75% |
8 |
C:early endosome; C:actin filament; C:lysosome; F:protein binding; P:zinc ion transport; C:organelle membrane; F:zinc ion binding; F:nucleotide binding |
|
|
contig03392 |
importin 5 |
258 |
20 |
1.81E-11 |
92.05% |
8 |
F:protein transporter activity; F:Ran GTPase binding; F:GTPase inhibitor activity; C:nuclear pore; F:nuclear localization sequence binding; P:NLS-bearing substrate import into nucleus; C:cytoplasm; P:protein import into nucleus, docking |
|
|
contig03393 |
ring finger protein 4 |
588 |
20 |
1.93E-50 |
75.10% |
8 |
F:androgen receptor binding; P:regulation of transcription from RNA polymerase II promoter; F:zinc ion binding; F:transcription factor activity; F:transcription coactivator activity; P:positive regulation of transcription, DNA-dependent; P:androgen receptor signaling pathway; C:nucleus |
|
|
contig03394 |
serum amyloid a-like 1 |
553 |
20 |
1.30E-15 |
53.65% |
3 |
P:acute-phase response; F:binding; C:extracellular region |
|
|
contig03395 |
c13orf27 homolog |
110 |
11 |
5.49E-08 |
81.00% |
0 |
|
|
|
contig03396 |
crooked neck pre-mrna splicing factor-like 1 |
1375 |
20 |
4.37E-126 |
59.70% |
2 |
C:intracellular; P:RNA processing |
|
|
contig03397 |
novel protein |
483 |
14 |
3.61E-52 |
75.00% |
1 |
C:membrane |
|
|
contig03398 |
---NA--- |
355 |
0 |
|
|
0 |
|
|
|
contig03399 |
fbxo11 protein |
220 |
20 |
4.77E-36 |
71.50% |
11 |
P:ubiquitin-dependent protein catabolic process; F:zinc ion binding; F:peptidyl-arginine C-methyltransferase activity; F:ubiquitin-protein ligase activity; P:protein ubiquitination; F:protein binding; F:histone-arginine N-methyltransferase activity; C:ubiquitin ligase complex; P:sensory perception of sound; C:cytoplasm; C:nucleus |
EC:6.3.2.19; EC:2.1.1.125 |
|
contig03400 |
sp1 transcription factor |
465 |
20 |
1.91E-45 |
59.25% |
19 |
P:positive regulation of transcription from RNA polymerase II promoter, global; P:lung development; P:ossification; F:double-stranded DNA binding; P:embryonic skeletal system development; P:definitive hemopoiesis; P:enucleate erythrocyte differentiation; P:liver development; F:protein C-terminus binding; P:embryonic process involved in female pregnancy; F:sequence-specific DNA binding; P:embryonic placenta development; F:transcription activator activity; F:transcription factor activity; P:megakaryocyte differentiation; P:trophectodermal cell differentiation; F:protein homodimerization activity; P:embryonic camera-type eye morphogenesis; C:nucleus |
|
|
100 Rows returned.